Patients with high-grade glioma that undergo standard-of-care (SOC) treatment with concurrent radiation and alkylating temozolomide (TMZ) may demonstrate CD4+ lymphopenia, which increases the patient’s risk for infections including Pneumocystis jiroveci pneumonia (PJP, formally known as PCP) [53]. The gene discussed is CD4; the disease is pneumocystosis.